Mural Oncology plc

Contributing Author

Recent Articles by Mural Oncology plc

Dec-05	Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition GlobeNewswire
Dec-03	Mural Oncology Announces Sanction of the Scheme by the High Court GlobeNewswire
Nov-26	Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty GlobeNewswire
Oct-24	Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty GlobeNewswire
Sep-23	Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting GlobeNewswire
Aug-20	Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share GlobeNewswire
Aug-04	Mural Oncology Announces Second Quarter Financial Results and Provides Business Update GlobeNewswire
May-19	Mural Oncology Announces Number of Relevant Securities in Issue GlobeNewswire